Breaking News
A Million People On Mars
SpaceX Acquires Cursor AI In $60 Billion Deal As Coding Agent Race Heats Up
From Hormuz To Houston: The US Takeover Of Global Energy Flows Ramps Up
US Housing Starts Collapsed In May To Lowest Since COVID
Top Tech News
Heads up: Apparently the government is hiding cameras inside fake utility boxes
Sodium Batteries And EVs That Power The Grid: Inside GM's Big Energy Push
NUCLEAR ENGINE - UNLIMITED LUXURY - 20 YEARS WITHOUT REFUELING
China Unveils Nuclear-Powered Floating Hub For Green Shipping
China Launches World's 1st Commercial Brain Chip, Beating Elon Musk's Neuralink!
Modular next-gen US nuclear reactor goes critical
How EMF's cause disease
This Company Will Add Phone, AirPod, and Smartwatch Trackers to License Plate Readers
Elon Details SpaceX AI Data Center in Space Details and Roadmap
5-in-1 miniature surgical robot is the size of a seed 
This Startup Will Let You Have A Younger Person's Blood For $8,000
Business Insider reported on the company first, while admitting there is little to no evidence that the procedure actually works.
But that hasn't stopped Amborisa creator Jesse Karmazin, from accepting payments via PayPal for the procedure: he is charging $8,000 for one liter of young blood and $12,000 for two liters. Karmazin, who isn't a licensed medical practitioner, told reporters last year that he had hoped to open his first clinic in New York City by the end of 2018. New York City has eluded him and instead he has opened locations in places like Los Angeles, San Francisco, Tampa and Houston.
Just like Theranos, the company also performed its own clinical trial to figure out what the effects of blood swapping would be. These results haven't been made public, but Karmazin has called them "really positive".